The TB-specific CD4+ T cell immune repertoire in both cynomolgus and rhesus macaques largely overlap with humans

Tuberculosis

Volumn 95, Issue 6, 2015, Pages 722-735

  Mothé, Bianca R ^a,b   Lindestam Arlehamn, Cecilia S ^b   Dow, Courtney ^a   Dillon, Myles B C ^b   Wiseman, Roger W ^c   Bohn, Patrick ^c   Karl, Julie ^c   Golden, Nadia A ^d   Gilpin, Trey ^a   Foreman, Taylor W ^d   Rodgers, Mark A ^e   Mehra, Smriti ^d,f   Scriba, Thomas J ^g   Flynn, Joanne L ^e   Kaushal, Deepak ^d   O'Connor, David H ^c   Sette, Alessandro ^b  

^a CALIFORNIA STATE UNIVERSITY   (United States)

^b LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^c UNIVERSITY OF WISCONSIN   (United States)

^d TULANE NATIONAL PRIMATE RESEARCH CENTER   (United States)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^f LOUISIANA STATE UNIVERSITY   (United States)

^g UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

CD4+; Epitopes; Non human primate

Indexed keywords

CD4 ANTIGEN; EPITOPE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; BACTERIAL ANTIGEN; BCG VACCINE; HLA ANTIGEN CLASS 2;

ADULT; ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN RECOGNITION; ARTICLE; BCG VACCINATION; CD4+ T LYMPHOCYTE; COHORT ANALYSIS; CONTROLLED STUDY; EX VIVO STUDY; HUMAN; IMMUNE RESPONSE; INBREEDING; MACACA FASCICULARIS; MYCOBACTERIUM BOVIS BCG; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PEDIGREE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RHESUS MONKEY; SEQUENCE HOMOLOGY; SPLEEN CELL; TUBERCULOSIS; ANIMAL; COMPARATIVE STUDY; DISEASE MODEL; ENZYME LINKED IMMUNOSPOT ASSAY; EPITOPE MAPPING; HOST PATHOGEN INTERACTION; IMMUNOLOGY; INTERFERON GAMMA RELEASE ASSAY; MICROBIOLOGY; PATHOGENICITY; SPECIES DIFFERENCE;

ANIMALS; ANTIGENS, BACTERIAL; BCG VACCINE; CD4-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSPOT ASSAY; EPITOPE MAPPING; HISTOCOMPATIBILITY ANTIGENS CLASS II; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNODOMINANT EPITOPES; INTERFERON-GAMMA RELEASE TESTS; MACACA FASCICULARIS; MACACA MULATTA; MYCOBACTERIUM TUBERCULOSIS; SPECIES SPECIFICITY; TUBERCULOSIS;

EID: 84948657132     PISSN: 14729792     EISSN: 1873281X     Source Type: Journal    
DOI: 10.1016/j.tube.2015.07.005     Document Type: Article

References (140)

1. N.G. de Groot, N. Otting, J. Robinson, A. Blancher, B.A. Lafont, S.G. Marsh, D.H. O'Connor, T. Shiina, L. Walter, D.I. Watkins, and R.E. Bontrop Nomenclature report on the major histocompatibility complex genes and alleles of great ape, old and new world monkey species Immunogenetics 64 2012 615 631 10.1007/s00251-012-0617-1
2. I. Hoof, B. Peters, J. Sidney, L.E. Pedersen, A. Sette, O. Lund, S. Buus, and M. Nielsen NetMHCpan, a method for MHC class I binding prediction beyond humans Immunogenetics 61 2009 1 13 10.1007/s00251-008-0341-z
3. T.M. Allen, B.R. Mothe, J. Sidney, P. Jing, J.L. Dzuris, M.E. Liebl, T.U. Vogel, D.H. O'Connor, X. Wang, M.C. Wussow, J.A. Thomson, J.D. Altman, D.I. Watkins, and A. Sette CD8(+) lymphocytes from simian immunodeficiency virus-infected rhesus macaques recognize 14 different epitopes bound by the major histocompatibility complex class I molecule Mamu-A∗01: implications for vaccine design and testing J Virol 75 2001 738 749
4. T.M. Allen, J. Sidney, M.F. del Guercio, R.L. Glickman, G.L. Lensmeyer, D.A. Wiebe, R. DeMars, C.D. Pauza, R.P. Johnson, A. Sette, and D.I. Watkins Characterization of the peptide binding motif of a rhesus MHC class I molecule (Mamu-A∗01) that binds an immunodominant CTL epitope from simian immunodeficiency virus J Immunol 160 1998 6062 6071
5. T.M. Allen, T.U. Vogel, D.H. Fuller, B.R. Mothe, S. Steffen, J.E. Boyson, T. Shipley, J. Fuller, T. Hanke, A. Sette, J.D. Altman, B. Moss, A.J. McMichael, and D.I. Watkins Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA prime/modified vaccinia virus Ankara boost regimen J Immunol 164 2000 4968 4978
6. A.J. Blasky, J.A. Karl, R.W. Wiseman, D.S. Read, and D.H. O'Connor Rapid high-resolution MHC class I genotyping of Chinese rhesus macaques by capillary reference strand-mediated conformational analysis Immunogenetics 60 2008 575 584 10.1007/s00251-008-0315-1
7. M. Carrington, and R.E. Bontrop Effects of MHC class I on HIV/SIV disease in primates AIDS 16 Suppl. 4 2002 S105 S114
8. J.L. Dzuris, J. Sidney, E. Appella, R.W. Chesnut, D.I. Watkins, and A. Sette Conserved MHC class I peptide binding motif between humans and rhesus macaques J Immunol 164 2000 283 291
9. J.L. Dzuris, J. Sidney, H. Horton, R. Correa, D. Carter, R.W. Chesnut, D.I. Watkins, and A. Sette Molecular determinants of peptide binding to two common rhesus macaque major histocompatibility complex class II molecules J Virol 75 2001 10958 10968
10. S.V. Joag Primate models of AIDS Microb Infect 2 2000 223 229 doi: S1286-4579(00)00266-5 [pii]
11. J.A. Karl, R.W. Wiseman, K.J. Campbell, A.J. Blasky, A.L. Hughes, B. Ferguson, D.S. Read, and D.H. O'Connor Identification of MHC class I sequences in Chinese-origin rhesus macaques Immunogenetics 60 2008 37 46 10.1007/s00251-007-0267-x
12. A. Li, X. Wang, Y. Liu, Y. Zhao, B. Liu, L. Sui, L. Zeng, and Z. Sun Preliminary observations of MHC class I A region polymorphism in three populations of Chinese-origin rhesus macaques Immunogenetics 64 2012 887 894 10.1007/s00251-012-0645-x
13. J.T. Loffredo, J. Maxwell, Y. Qi, C.E. Glidden, G.J. Borchardt, T. Soma, A.T. Bean, D.R. Beal, N.A. Wilson, W.M. Rehrauer, J.D. Lifson, M. Carrington, and D.I. Watkins Mamu-B∗08-positive macaques control simian immunodeficiency virus replication J Virol 81 2007 8827 8832 doi: JVI.00895-07 [pii] 10.1128/JVI.00895-07
14. J.T. Loffredo, J. Sidney, A.T. Bean, D.R. Beal, W. Bardet, A. Wahl, O.E. Hawkins, S. Piaskowski, N.A. Wilson, W.H. Hildebrand, D.I. Watkins, and A. Sette Two MHC class I molecules associated with elite control of immunodeficiency virus replication, Mamu-B∗08 and HLA-B∗2705, bind peptides with sequence similarity J Immunol 182 2009 7763 7775 doi: 182/12/7763 [pii] 10.4049/jimmunol.0900111
15. J.T. Loffredo, J. Sidney, S. Piaskowski, A. Szymanski, J. Furlott, R. Rudersdorf, J. Reed, B. Peters, H.D. Hickman-Miller, W. Bardet, W.M. Rehrauer, D.H. O'Connor, N.A. Wilson, W.H. Hildebrand, A. Sette, and D.I. Watkins The high frequency Indian rhesus macaque MHC class I molecule, Mamu-B∗01, does not appear to be involved in CD8+ T lymphocyte responses to SIVmac239 J Immunol 175 2005 5986 5997 doi: 175/9/5986 [pii]
16. J.T. Loffredo, J. Sidney, C. Wojewoda, E. Dodds, M.R. Reynolds, G. Napoe, B.R. Mothe, D.H. O'Connor, N.A. Wilson, D.I. Watkins, and A. Sette Identification of seventeen new simian immunodeficiency virus-derived CD8+ T cell epitopes restricted by the high frequency molecule, Mamu-A∗02, and potential escape from CTL recognition J Immunol 173 2004 5064 5076
17. J.T. Loffredo, J. Sidney, S. Piaskowski, A. Szymanski, J. Furlott, R. Rudersdorf, J. Reed, B. Peters, H.D. Hickman-Miller, W. Bardet, W.M. Rehrauer, D.H. O'Connor, N.A. Wilson, W.H. Hildebrand, A. Sette, and D.I. Watkins The high frequency Indian rhesus macaque MHC class I molecule, Mamu-B∗01, does not appear to be involved in CD8+ T lymphocyte responses to SIVmac239 J Immunol 175 2005 5986 5997
18. N.J. Maness, A.D. Walsh, R.A. Rudersdorf, P.A. Erickson, S.M. Piaskowski, N.A. Wilson, and D.I. Watkins Chinese origin rhesus macaque major histocompatibility complex class I molecules promiscuously present epitopes from SIV associated with molecules of Indian origin; implications for immunodominance and viral escape Immunogenetics 63 2011 587 597 10.1007/s00251-011-0538-4
19. B.R. Mothe, J. Weinfurter, C. Wang, W. Rehrauer, N. Wilson, T.M. Allen, D.B. Allison, and D.I. Watkins Expression of the major histocompatibility complex class I molecule Mamu-A∗01 is associated with control of simian immunodeficiency virus SIVmac239 replication J Virol 77 2003 2736 2740
20. B.R. Mothe, H. Horton, D.K. Carter, T.M. Allen, M.E. Liebl, P. Skinner, T.U. Vogel, S. Fuenger, K. Vielhuber, W. Rehrauer, N. Wilson, G. Franchini, J.D. Altman, A. Haase, L.J. Picker, D.B. Allison, and D.I. Watkins Dominance of CD8 responses specific for epitopes bound by a single major histocompatibility complex class I molecule during the acute phase of viral infection J Virol 76 2002 875 884
21. B.R. Mothe, J. Sidney, J.L. Dzuris, M.E. Liebl, S. Fuenger, D.I. Watkins, and A. Sette Characterization of the peptide-binding specificity of Mamu-B∗17 and identification of Mamu-B∗17-restricted epitopes derived from simian immunodeficiency virus proteins J Immunol 169 2002 210 219
22. T. Muhl, M. Krawczak, P. Ten Haaft, G. Hunsmann, and U. Sauermann MHC class I alleles influence set-point viral load and survival time in simian immunodeficiency virus-infected rhesus monkeys J Immunol 169 2002 3438 3446
23. D.H. O'Connor, B.R. Mothe, J.T. Weinfurter, S. Fuenger, W.M. Rehrauer, P. Jing, R.R. Rudersdorf, M.E. Liebl, K. Krebs, J. Vasquez, E. Dodds, J. Loffredo, S. Martin, A.B. McDermott, T.M. Allen, C. Wang, G.G. Doxiadis, D.C. Montefiori, A. Hughes, D.R. Burton, D.B. Allison, S.M. Wolinsky, R. Bontrop, L.J. Picker, and D.I. Watkins Major histocompatibility complex class I alleles associated with slow simian immunodeficiency virus disease progression bind epitopes recognized by dominant acute-phase cytotoxic-T-lymphocyte responses J Virol 77 2003 9029 9040
24. N. Otting, A.J. de Vos-Rouweler, C.M. Heijmans, N.G. de Groot, G.G. Doxiadis, and R.E. Bontrop MHC class I A region diversity and polymorphism in macaque species Immunogenetics 59 2007 367 375 10.1007/s00251-007-0201-2
25. N. Otting, C.M. Heijmans, M. van der Wiel, N.G. de Groot, G.G. Doxiadis, and R.E. Bontrop A snapshot of the Mamu-B genes and their allelic repertoire in rhesus macaques of Chinese origin Immunogenetics 60 2008 507 514 10.1007/s00251-008-0311-5
26. D. Ouyang, X. Wang, X. He, L. Xu, H. Shi, Q. Gao, and H. Guo Construction of soluble Mamu-b∗1703, a class I major histocompatibility complex of Chinese rhesus macaques, monomer and tetramer loaded with a simian immunodeficiency virus peptide Cell Mol Immunol 6 2009 117 122 10.1038/cmi.2009.16
27. D. Ouyang, L. Xu, Z. Dai, H. Shi, G. Zhang, Y. Zheng, and X. He Identification of major histocompatibility complex class I alleles in Chinese rhesus macaques Acta Biochim Biophys Sin (Shanghai) 40 2008 919 927
28. D.Y. Ouyang, L.H. Xu, H.J. Shi, Y.T. Zheng, and X.H. He Eight novel MHC class I alleles identified in Chinese-origin rhesus macaques Tissue Antigens 73 2009 285 287 10.1111/j.1399-0039.2008.01198.x
29. C.L. Qiu, G.B. Yang, K. Yu, Y. Li, X.L. Li, Q. Liu, H. Zhao, H. Xing, and Y. Shao Characterization of the major histocompatibility complex class II DQB (MhcMamu-DQB1) alleles in a cohort of Chinese rhesus macaques (Macaca mulatta) Hum Immunol 69 2008 513 521 10.1016/j.humimm.2008.05.014
30. U. Sauermann Making the animal model for AIDS research more precise: the impact of major histocompatibility complex (MHC) genes on pathogenesis and disease progression in SIV-infected monkeys Curr Mol Med 1 2001 515 522
31. A. Sette, J. Sidney, H.H. Bui, M.F. Del Guercio, J. Alexander, J. Loffredo, D.I. Watkins, and B.R. Mothe Characterization of the peptide-binding specificity of Mamu-A∗11 results in the identification of SIV-derived epitopes and interspecies cross-reactivity Immunogenetics 57 2005 53 68
32. A. Sette, J. Sidney, B. Livingston, J. Dzuris, C. Crimi, C.M. Walker, S. Southwood, E.J. Collins, and A. Hughes Class I molecules with similar peptide binding specificities are the result of both common ancestry and convergent evolution Immunogenetics 54 2003 830 841
33. J. Sidney, J.L. Dzuris, M.J. Newman, R.P. Johnson, A. Kaur, K. Amitinder, C.M. Walker, E. Appella, B. Mothe, D.I. Watkins, and A. Sette Definition of the Mamu A∗01 peptide binding specificity: application to the identification of wild-type and optimized ligands from simian immunodeficiency virus regulatory proteins J Immunol 165 2000 6387 6399
34. C. Solomon, S. Southwood, I. Hoof, R. Rudersdorf, B. Peters, J. Sidney, C. Pinilla, M.C. Marcondes, B. Ling, P. Marx, A. Sette, and B.R. Mothe The most common Chinese rhesus macaque MHC class I molecule shares peptide binding repertoire with the HLA-B7 supertype Immunogenetics 62 2010 451 464 10.1007/s00251-010-0450-3
35. S. Southwood, C. Solomon, I. Hoof, R. Rudersdorf, J. Sidney, B. Peters, A. Wahl, O. Hawkins, W. Hildebrand, B.R. Mothe, and A. Sette Functional analysis of frequently expressed Chinese rhesus macaque MHC class I molecules Mamu-A1∗02601 and Mamu-B∗08301 reveals HLA-A2 and HLA-A3 supertypic specificities Immunogenetics 63 2011 275 290 10.1007/s00251-010-0502-8
36. T. Vogel, S. Norley, B. Beer, and R. Kurth Rapid screening for Mamu-A1-positive rhesus macaques using a SIVmac Gag peptide-specific cytotoxic T-lymphocyte assay Immunology 84 1995 482 487
37. T.U. Vogel, D.T. Evans, J.A. Urvater, D.H. O'Connor, A.L. Hughes, and D.I. Watkins Major histocompatibility complex class I genes in primates: co-evolution with pathogens Immunol Rev 167 1999 327 337
38. T.U. Vogel, T.C. Friedrich, D.H. O'Connor, W. Rehrauer, E.J. Dodds, H. Hickman, W. Hildebrand, J. Sidney, A. Sette, A. Hughes, H. Horton, K. Vielhuber, R. Rudersdorf, I.P. De Souza, M.R. Reynolds, T.M. Allen, N. Wilson, and D.I. Watkins Escape in one of two cytotoxic T-lymphocyte epitopes bound by a high-frequency major histocompatibility complex class I molecule, Mamu-A∗02: a paradigm for virus evolution and persistence? J Virol 76 2002 11623 11636
39. R.W. Wiseman, J.A. Karl, B.N. Bimber, C.E. O'Leary, S.M. Lank, J.J. Tuscher, A.M. Detmer, P. Bouffard, N. Levenkova, C.L. Turcotte, E. Szekeres Jr.; C. Wright, T. Harkins, and D.H. O'Connor Major histocompatibility complex genotyping with massively parallel pyrosequencing Nat Med 15 2009 1322 1326 doi: nm.2038 [pii] 10.1038/nm.2038
40. B.R. Mothe, S. Southwood, J. Sidney, A.M. English, A. Wriston, I. Hoof, J. Shabanowitz, D.F. Hunt, and A. Sette Peptide-binding motifs associated with MHC molecules common in Chinese rhesus macaques are analogous to those of human HLA supertypes and include HLA-B27-like alleles Immunogenetics 65 2013 371 386 10.1007/s00251-013-0686-9
41. A. Sette, J. Sidney, S. Southwood, C. Moore, J. Berry, C. Dow, K. Bradley, I. Hoof, M.G. Lewis, W.H. Hildebrand, C.P. McMurtrey, N.A. Wilson, D.I. Watkins, and B.R. Mothe A shared MHC supertype motif emerges by convergent evolution in macaques and mice, but is totally absent in human MHC molecules Immunogenetics 2012 10.1007/s00251-011-0598-5
42. T.M. Allen, P. Jing, B. Calore, H. Horton, D.H. O'Connor, T. Hanke, M. Piekarczyk, R. Ruddersdorf, B.R. Mothe, C. Emerson, N. Wilson, J.D. Lifson, I.M. Belyakov, J.A. Berzofsky, C. Wang, D.B. Allison, D.C. Montefiori, R.C. Desrosiers, S. Wolinsky, K.J. Kunstman, J.D. Altman, A. Sette, A.J. McMichael, and D.I. Watkins Effects of cytotoxic T lymphocytes (CTL) directed against a single simian immunodeficiency virus (SIV) Gag CTL epitope on the course of SIVmac239 infection J Virol 76 2002 10507 10511
43. J. Greenbaum, J. Sidney, J. Chung, C. Brander, B. Peters, and A. Sette Functional classification of class II human leukocyte antigen (HLA) molecules reveals seven different supertypes and a surprising degree of repertoire sharing across supertypes Immunogenetics 63 2011 325 335 10.1007/s00251-011-0513-0
44. A. Zumla, A. George, V. Sharma, N. Herbert Baroness Masham of I WHO's 2013 global report on tuberculosis: successes, threats, and opportunities Lancet 382 2013 1765 1767 10.1016/S0140-6736(13)62078-4
45. G.W. Comstock Epidemiology of tuberculosis Am Rev Respir Dis 125 1982 8 15
46. S.H. Kaufmann Is the development of a new tuberculosis vaccine possible? Nat Med 6 2000 955 960 10.1038/79631
47. N.D. Walter, J. Painter, M. Parker, P. Lowenthal, J. Flood, Y. Fu, R. Asis, R. Reves Tuberculosis epidemiologic studies C Persistent latent tuberculosis reactivation risk in United States immigrants Am J Respir Crit Care Med 189 2014 88 95 10.1164/rccm.201308-1480OC
48. P. Andersen, and T.M. Doherty The success and failure of BCG - implications for a novel tuberculosis vaccine Nat Rev Microbiol 3 2005 656 662 10.1038/nrmicro1211
49. T.M. Doherty Real world TB vaccines: clinical trials in TB-endemic regions Vaccine 23 2005 2109 2114 10.1016/j.vaccine.2005.01.060
50. C. Bonah Packaging BCG: standardizing an anti-tuberculosis vaccine in interwar Europe Sci Context 21 2008 279 310
51. M. Tameris, H. Geldenhuys, A.K. Luabeya, E. Smit, J.E. Hughes, S. Vermaak, W.A. Hanekom, M. Hatherill, H. Mahomed, H. McShane, and T.J. Scriba The candidate TB vaccine, MVA85A, induces highly durable Th1 responses PLoS One 9 2014 e87340 10.1371/journal.pone.0087340
52. G.A. Colditz, C.S. Berkey, F. Mosteller, T.F. Brewer, M.E. Wilson, E. Burdick, and H.V. Fineberg The efficacy of bacillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature Pediatrics 96 1995 29 35
53. A. Calmette Preventive vaccination against tuberculosis with BCG Proc R Soc Med 24 1931 1481 1490
54. M.D. Tameris, M. Hatherill, B.S. Landry, T.J. Scriba, M.A. Snowden, S. Lockhart, J.E. Shea, J.B. McClain, G.D. Hussey, W.A. Hanekom, H. Mahomed, H. McShane, and M.A.T.S. Team Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial Lancet 381 2013 1021 1028 10.1016/S0140-6736(13)60177-4
55. R. Rustomjee, S. Lockhart, J. Shea, P.B. Fourie, Z. Hindle, G. Steel, G. Hussey, A. Ginsberg, and M.J. Brennan Novel licensure pathways for expeditious introduction of new tuberculosis vaccines: a discussion of the adaptive licensure concept Tuberc Edinb Scotl 94 2014 178 182 10.1016/j.tube.2013.11.002
56. I. Orme, and M. Gonzalez-Juarrero Animal models of M. Tuberculosis infection Curr Protoc Microbiol 2007 10.1002/9780471729259.mc10a05s7 [Chapter 10]:Unit 10A 15
57. I. Orme Cellular and genetic mechanisms underlying susceptibility of animal models to tuberculosis infection Novartis Found Symp 217 1998 112 117 discussion 117-119
58. H. McShane, and A. Williams A review of preclinical animal models utilised for TB vaccine evaluation in the context of recent human efficacy data Tuberc Edinb Scotl 94 2014 105 110 10.1016/j.tube.2013.11.003
59. D. Ordway, G. Palanisamy, M. Henao-Tamayo, E.E. Smith, C. Shanley, I.M. Orme, and R.J. Basaraba The cellular immune response to Mycobacterium tuberculosis infection in the guinea pig J Immunol 179 2007 2532 2541
60. S. Shang, M. Harton, M.H. Tamayo, C. Shanley, G.S. Palanisamy, M. Caraway, E.D. Chan, R.J. Basaraba, I.M. Orme, and D.J. Ordway Increased Foxp3 expression in guinea pigs infected with W-Beijing strains of M. Tuberculosis Tuberc Edinb Scotl 91 2011 378 385 10.1016/j.tube.2011.06.001
61. J.A. Tree, S. Smith, N. Baker, S. Clark, F.E. Aldwell, M. Chambers, A. Williams, and P.D. Marsh Method for assessing IFN-gamma responses in guinea pigs during TB vaccine trials Lett Appl Microbiol 55 2012 295 300 10.1111/j.1472-765X.2012.03292.x
62. N.P. Goonetilleke, H. McShane, C.M. Hannan, R.J. Anderson, R.H. Brookes, and A.V. Hill Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guerin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara J Immunol 171 2003 1602 1609
63. A. Williams, N.P. Goonetilleke, H. McShane, S.O. Clark, G. Hatch, S.C. Gilbert, and A.V. Hill Boosting with poxviruses enhances Mycobacterium bovis BCG efficacy against tuberculosis in guinea pigs Infect Immun 73 2005 3814 3816 10.1128/IAI.73.6.3814-3816.2005
64. A. Williams, G.J. Hatch, S.O. Clark, K.E. Gooch, K.A. Hatch, G.A. Hall, K. Huygen, T.H. Ottenhoff, K.L. Franken, P. Andersen, T.M. Doherty, S.H. Kaufmann, L. Grode, P. Seiler, C. Martin, B. Gicquel, S.T. Cole, P. Brodin, A.S. Pym, W. Dalemans, J. Cohen, Y. Lobet, N. Goonetilleke, H. McShane, A. Hill, T. Parish, D. Smith, N.G. Stoker, D.B. Lowrie, G. Kallenius, S. Svenson, A. Pawlowski, K. Blake, and P.D. Marsh Evaluation of vaccines in the EU TB vaccine cluster using a guinea pig aerosol infection model of tuberculosis Tuberc Edinb Scotl 85 2005 29 38 10.1016/j.tube.2004.09.009
65. F.A. Verreck, R.A. Vervenne, I. Kondova, K.W. van Kralingen, E.J. Remarque, G. Braskamp, N.M. van der Werff, A. Kersbergen, T.H. Ottenhoff, P.J. Heidt, S.C. Gilbert, B. Gicquel, A.V. Hill, C. Martin, H. McShane, and A.W. Thomas MVA.85A boosting of BCG and an attenuated, phoP deficient M. Tuberculosis vaccine both show protective efficacy against tuberculosis in rhesus macaques PLoS One 4 2009 e5264 10.1371/journal.pone.0005264
66. W.R. Waters, M.V. Palmer, B.M. Buddle, and H.M. Vordermeier Bovine tuberculosis vaccine research: historical perspectives and recent advances Vaccine 30 2012 2611 2622 10.1016/j.vaccine.2012.02.018
67. H.M. Vordermeier, B. Villarreal-Ramos, P.J. Cockle, M. McAulay, S.G. Rhodes, T. Thacker, S.C. Gilbert, H. McShane, A.V. Hill, Z. Xing, and R.G. Hewinson Viral booster vaccines improve Mycobacterium bovis BCG-induced protection against bovine tuberculosis Infect Immun 77 2009 3364 3373 10.1128/IAI.00287-09
68. D.N. McMurray Disease model: pulmonary tuberculosis Trends Mol Med 7 2001 135 137
69. D. Kaushal, S. Mehra, P.J. Didier, and A.A. Lackner The non-human primate model of tuberculosis J Med Primatol 41 2012 191 201 10.1111/j.1600-0684.2012.00536.x
70. B. Pahar, J. Li, T. Rourke, C.J. Miller, and M.B. McChesney Detection of antigen-specific T cell interferon gamma expression by ELISPOT and cytokine flow cytometry assays in rhesus macaques J Immunol Methods 282 2003 103 115
71. R.R. Amara Methods for quantitating antigen-specific T cell responses using functional assays in rhesus macaques Methods Mol Biol 485 2009 417 424 10.1007/978-1-59745-170-3-28
72. S.A. Sharpe, H. McShane, M.J. Dennis, R.J. Basaraba, F. Gleeson, G. Hall, A. McIntyre, K. Gooch, S. Clark, N.E. Beveridge, E. Nuth, A. White, A. Marriott, S. Dowall, A.V. Hill, A. Williams, and P.D. Marsh Establishment of an aerosol challenge model of tuberculosis in rhesus macaques and an evaluation of endpoints for vaccine testing Clin Vaccin Immunol 17 2010 1170 1182 10.1128/CVI.00079-10
73. M.J. Harriff, M.E. Cansler, K.G. Toren, E.T. Canfield, S. Kwak, M.C. Gold, and D.M. Lewinsohn Human lung epithelial cells contain Mycobacterium tuberculosis in a late endosomal vacuole and are efficiently recognized by CD8(+) T cells PloS One 9 2014 e97515 10.1371/journal.pone.0097515
74. T. Prezzemolo, G. Guggino, M.P. La Manna, D. Di Liberto, F. Dieli, and N. Caccamo Functional signatures of human CD4 and CD8 T Cell responses to Mycobacterium tuberculosis Front Immunol 5 2014 180 10.3389/fimmu.2014.00180
75. J.E. Ussher, P. Klenerman, and C.B. Willberg Mucosal-associated invariant T-cells: new players in anti-bacterial immunity Front Immunol 5 2014 450 10.3389/fimmu.2014.00450
76. M.C. Boer, K.E. van Meijgaarden, S.A. Joosten, and T.H. Ottenhoff CD8+ regulatory T cells, and not CD4+ T cells, dominate suppressive phenotype and function after in vitro live Mycobacterium bovis-BCG activation of human cells PloS One 9 2014 e94192 10.1371/journal.pone.0094192
77. S. Commandeur, M.Y. Lin, K.E. van Meijgaarden, A.H. Friggen, K.L. Franken, J.W. Drijfhout, G.E. Korsvold, F. Oftung, A. Geluk, and T.H. Ottenhoff Double- and monofunctional CD4(+) and CD8(+) T-cell responses to Mycobacterium tuberculosis DosR antigens and peptides in long-term latently infected individuals Eur J Immunol 41 2011 2925 2936 10.1002/eji.201141602
78. J.M. Young, I.M. Adetifa, M.O. Ota, and J.S. Sutherland Expanded polyfunctional T cell response to mycobacterial antigens in TB disease and contraction post-treatment PloS One 5 2010 e11237 10.1371/journal.pone.0011237
79. C. Nunes-Alves, M.G. Booty, S.M. Carpenter, P. Jayaraman, A.C. Rothchild, and S.M. Behar In search of a new paradigm for protective immunity to TB Nat Rev Microbiol 12 2014 289 299 10.1038/nrmicro3230
80. N. Caccamo, G. Guggino, S.A. Joosten, G. Gelsomino, P. Di Carlo, L. Titone, D. Galati, M. Bocchino, A. Matarese, A. Salerno, A. Sanduzzi, W.P. Franken, T.H. Ottenhoff, and F. Dieli Multifunctional CD4(+) T cells correlate with active Mycobacterium tuberculosis infection Eur J Immunol 40 2010 2211 2220 10.1002/eji.201040455
81. C.L. Arlehamn, G. Seumois, A. Gerasimova, C. Huang, Z. Fu, X. Yue, A. Sette, P. Vijayanand, and B. Peters Transcriptional profile of tuberculosis antigen-specific T cells reveals novel multifunctional features J Immunol 193 2014 2931 2940 10.4049/jimmunol.1401151
82. D.A. Lewinsohn, E. Winata, G.M. Swarbrick, K.E. Tanner, M.S. Cook, M.D. Null, M.E. Cansler, A. Sette, J. Sidney, and D.M. Lewinsohn Immunodominant tuberculosis CD8 antigens preferentially restricted by HLA-B PLoS Pathog 3 2007 1240 1249 10.1371/journal.ppat.0030127
83. C.S. Arlehamn, J. Sidney, R. Henderson, J.A. Greenbaum, E.A. James, M. Moutaftsi, R. Coler, D.M. McKinney, D. Park, R. Taplitz, W.W. Kwok, H. Grey, B. Peters, and A. Sette Dissecting mechanisms of immunodominance to the common tuberculosis antigens ESAT-6, CFP10, Rv2031c (hspX), Rv2654c (TB7.7), and Rv1038c (EsxJ) J Immunol 188 2012 5020 5031 10.4049/jimmunol.1103556
84. H. Wei, R. Wang, Z. Yuan, C.Y. Chen, D. Huang, L. Halliday, W. Zhong, G. Zeng, Y. Shen, L. Shen, Y. Wang, and Z.W. Chen DR∗W201/P65 tetramer visualization of epitope-specific CD4 T-cell during M. Tuberculosis infection and its resting memory pool after BCG vaccination PLoS One 4 2009 e6905 10.1371/journal.pone.0006905
85. D. Kaushal, B.G. Schroeder, S. Tyagi, T. Yoshimatsu, C. Scott, C. Ko, L. Carpenter, J. Mehrotra, Y.C. Manabe, R.D. Fleischmann, and W.R. Bishai Reduced immunopathology and mortality despite tissue persistence in a Mycobacterium tuberculosis mutant lacking alternative sigma factor, SigH Proc Natl Acad Sci U S A 99 2002 8330 8335 10.1073/pnas.102055799
86. S. Mehra, and D. Kaushal Functional genomics reveals extended roles of the Mycobacterium tuberculosis stress response factor sigmaH J Bacteriol 191 2009 3965 3980 10.1128/JB.00064-09
87. L. Garcia-Contreras, Y.L. Wong, P. Muttil, D. Padilla, J. Sadoff, J. Derousse, W.A. Germishuizen, S. Goonesekera, K. Elbert, B.R. Bloom, R. Miller, P.B. Fourie, A. Hickey, and D. Edwards Immunization by a bacterial aerosol Proc Natl Acad Sci U S A 105 2008 4656 4660 10.1073/pnas.0800043105
88. W.R. Barclay, W.M. Busey, D.W. Dalgard, R.C. Good, B.W. Janicki, J.E. Kasik, E. Ribi, C.E. Ulrich, and E. Wolinsky Protection of monkeys against airborne tuberculosis by aerosol vaccination with bacillus Calmette-Guerin Am Rev Respir Dis 107 1973 351 358
89. S. Sadagopal, M. Braunstein, C.C. Hager, J. Wei, A.K. Daniel, M.R. Bochan, I. Crozier, N.E. Smith, H.O. Gates, L. Barnett, L. Van Kaer, J.O. Price, T.S. Blackwell, S.A. Kalams, and D.S. Kernodle Reducing the activity and secretion of microbial antioxidants enhances the immunogenicity of BCG PLoS One 4 2009 e5531 10.1371/journal.pone.0005531
90. P.L. Lin, M. Rodgers, L. Smith, M. Bigbee, A. Myers, C. Bigbee, I. Chiosea, S.V. Capuano, C. Fuhrman, E. Klein, and J.L. Flynn Quantitative comparison of active and latent tuberculosis in the cynomolgus macaque model Infect Immun 77 2009 4631 4642 10.1128/IAI.00592-09
91. Z. Hel, J. Nacsa, B. Kelsall, W.P. Tsai, N. Letvin, R.W. Parks, E. Tryniszewska, L. Picker, M.G. Lewis, Y. Edghill-Smith, M. Moniuszko, R. Pal, L. Stevceva, J.D. Altman, T.M. Allen, D. Watkins, J.V. Torres, J.A. Berzofsky, I.M. Belyakov, W. Strober, and G. Franchini Impairment of Gag-specific CD8(+) T-cell function in mucosal and systemic compartments of simian immunodeficiency virus mac251- and simian-human immunodeficiency virus KU2-infected macaques J Virol 75 2001 11483 11495 10.1128/JVI.75.23.11483-11495.2001
92. C.S. Lindestam Arlehamn, A. Gerasimova, F. Mele, R. Henderson, J. Swann, J.A. Greenbaum, Y. Kim, J. Sidney, E.A. James, R. Taplitz, D.M. McKinney, W.W. Kwok, H. Grey, F. Sallusto, B. Peters, and A. Sette Memory T cells in latent Mycobacterium tuberculosis infection are directed against three antigenic islands and largely contained in a CXCR3+CCR6+ Th1 subset PLoS Pathog 9 2013 e1003130 10.1371/journal.ppat.1003130
93. B.R. Mothe, B.S. Stewart, C. Oseroff, H.H. Bui, S. Stogiera, Z. Garcia, C. Dow, M.P. Rodriguez-Carreno, M. Kotturi, V. Pasquetto, J. Botten, S. Crotty, E. Janssen, M.J. Buchmeier, and A. Sette Chronic lymphocytic choriomeningitis virus infection actively down-regulates CD4+ T cell responses directed against a broad range of epitopes J Immunol 179 2007 1058 1067 doi: 179/2/1058 [pii]
94. S. Tangri, B.R. Mothe, J. Eisenbraun, J. Sidney, S. Southwood, K. Briggs, J. Zinckgraf, P. Bilsel, M. Newman, R. Chesnut, C. Licalsi, and A. Sette Rationally engineered therapeutic proteins with reduced immunogenicity J Immunol 174 2005 3187 3196
95. C. Oseroff, J. Sidney, M.F. Kotturi, R. Kolla, R. Alam, D.H. Broide, S.I. Wasserman, D. Weiskopf, D.M. McKinney, J.L. Chung, A. Petersen, H. Grey, B. Peters, and A. Sette Molecular determinants of T cell epitope recognition to the common Timothy grass allergen J Immunol 185 2010 943 955 10.4049/jimmunol.1000405
96. M.R. Alderson, T. Bement, C.H. Day, L. Zhu, D. Molesh, Y.A. Skeiky, R. Coler, D.M. Lewinsohn, S.G. Reed, and D.C. Dillon Expression cloning of an immunodominant family of Mycobacterium tuberculosis antigens using human CD4(+) T cells J Exp Med 191 2000 551 560
97. G.G. Doxiadis, N. Otting, N.G. de Groot, and R.E. Bontrop Differential evolutionary MHC class II strategies in humans and rhesus macaques: relevance for biomedical studies Immunol Rev 183 2001 76 85
98. N. Otting, N.G. de Groot, M.C. Noort, G.G. Doxiadis, and R.E. Bontrop Allelic diversity of Mhc-DRB alleles in rhesus macaques Tissue Antigens 56 2000 58 68
99. N. de Groot, G.G. Doxiadis, N.G. De Groot, N. Otting, C. Heijmans, A.J. Rouweler, and R.E. Bontrop Genetic makeup of the DR region in rhesus macaques: gene content, transcripts, and pseudogenes J Immunol 172 2004 6152 6157
100. G. Li Pira, F. Ivaldi, C. Dentone, E. Righi, V. Del Bono, C. Viscoli, G. Koopman, and F. Manca Evaluation of antigen-specific T-cell responses with a miniaturized and automated method Clin Vaccin Immunol 15 2008 1811 1818 10.1128/CVI.00322-08
101. T. Ulrichs, M.E. Munk, H. Mollenkopf, S. Behr-Perst, R. Colangeli, M.L. Gennaro, and S.H. Kaufmann Differential T cell responses to Mycobacterium tuberculosis ESAT6 in tuberculosis patients and healthy donors Eur J Immunol 28 1998 3949 3958 10.1002/(SICI)1521-4141(199812)28 12<3949::AID-IMMU3949>3.0.CO;2-4
102. C.L. Day, N. Mkhwanazi, S. Reddy, Z. Mncube, M. van der Stok, P. Klenerman, and B.D. Walker Detection of polyfunctional Mycobacterium tuberculosis-specific T cells and association with viral load in HIV-1-infected persons J Infect Dis 197 2008 990 999 10.1086/529048
103. R. Axelsson-Robertson, A.G. Loxton, G. Walzl, M.M. Ehlers, M.M. Kock, A. Zumla, and M. Maeurer A broad profile of co-dominant epitopes shapes the peripheral Mycobacterium tuberculosis specific CD8+ T-cell immune response in South African patients with active tuberculosis PloS One 8 2013 e58309 10.1371/journal.pone.0058309
104. G. Tully, C. Kortsik, H. Hohn, I. Zehbe, W.E. Hitzler, C. Neukirch, K. Freitag, K. Kayser, and M.J. Maeurer Highly focused T cell responses in latent human pulmonary Mycobacterium tuberculosis infection J Immunol 174 2005 2174 2184
105. H. Shams, P. Klucar, S.E. Weis, A. Lalvani, P.K. Moonan, H. Safi, B. Wizel, K. Ewer, G.T. Nepom, D.M. Lewinsohn, P. Andersen, and P.F. Barnes Characterization of a Mycobacterium tuberculosis peptide that is recognized by human CD4+ and CD8+ T cells in the context of multiple HLA alleles J Immunol 173 2004 1966 1977
106. H. Nagai, M. Suzukawa, Y. Sakakibara, K. Ohta, P.A. Reche, K. Suzuki, and Y. Hoshino Immunological responses and epitope mapping by tuberculosis-associated antigens within the RD1 region in Japanese patients J Immunol Res 2014 2014 764028 10.1155/2014/764028
107. I. Comas, J. Chakravartti, P.M. Small, J. Galagan, S. Niemann, K. Kremer, J.D. Ernst, and S. Gagneux Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved Nat Genet 42 2010 498 503 10.1038/ng.590
108. P. Andersen, and J.S. Woodworth Tuberculosis vaccines-rethinking the current paradigm Trends Immunol 35 2014 387 395 10.1016/j.it.2014.04.006
109. A. Roy, M. Eisenhut, R.J. Harris, L.C. Rodrigues, S. Sridhar, S. Habermann, L. Snell, P. Mangtani, I. Adetifa, A. Lalvani, and I. Abubakar Effect of BCG vaccination against Mycobacterium tuberculosis infection in children: systematic review and meta-analysis BMJ Clin Res Ed 349 2014 10.1136/bmj.g4643 g4643
110. J.M. Yuk, and E.K. Jo Host immune responses to mycobacterial antigens and their implications for the development of a vaccine to control tuberculosis Clin Exp Vaccin Res 3 2014 155 167 10.7774/cevr.2014.3.2.155
111. J. Zhang, Q. Xian, M. Guo, Z. Huang, Y. Rao, Y. Wang, X. Wang, R. Bao, T.G. Evans, D. Hokey, D. Sizemore, and W.Z. Ho Mycobacterium tuberculosis Erdman infection of rhesus macaques of Chinese origin Tuberc Edinb Scotl 94 2014 634 643 10.1016/j.tube.2014.08.005
112. R. Ravindran, V.V. Krishnan, R. Dhawan, M.L. Wunderlich, N.W. Lerche, J.L. Flynn, P.A. Luciw, and I.H. Khan Plasma antibody profiles in non-human primate tuberculosis J Med Primatol 43 2014 59 71 10.1111/jmp.12097
113. F. Min, Y. Zhang, J. Pan, J. Wang, and W. Yuan Mycobacterium tuberculosis infection in rhesus monkeys (Macaca mulatta) and evaluation of ESAT-6 and CFP10 as immunodiagnostic antigens Exp Anim Jpn Assoc Lab Anim Sci 62 2013 281 293
114. A.D. White, L. Sibley, M.J. Dennis, K. Gooch, G. Betts, N. Edwards, A. Reyes-Sandoval, M.W. Carroll, A. Williams, P.D. Marsh, H. McShane, and S.A. Sharpe Evaluation of the safety and immunogenicity of a candidate tuberculosis vaccine, MVA85A, delivered by aerosol to the lungs of macaques Clin Vaccin Immunol 20 2013 663 672 10.1128/CVI.00690-12
115. D.M. Lewinsohn, I.S. Tydeman, M. Frieder, J.E. Grotzke, R.A. Lines, S. Ahmed, K.D. Prongay, S.L. Primack, L.M. Colgin, A.D. Lewis, and D.A. Lewinsohn High resolution radiographic and fine immunologic definition of TB disease progression in the rhesus macaque Microb Infect 8 2006 2587 2598 10.1016/j.micinf.2006.07.007
116. S.A. Clark, S.L. Martin, A. Pozniak, A. Steel, B. Ward, J. Dunning, D.C. Henderson, M. Nelson, B. Gazzard, and P. Kelleher Tuberculosis antigen-specific immune responses can be detected using enzyme-linked immunospot technology in human immunodeficiency virus (HIV)-1 patients with advanced disease Clin Exp Immunol 150 2007 238 244 10.1111/j.1365-2249.2007.03477.x
117. D.I. Won, and J.R. Park Flow cytometric measurements of TB-specific T cells comparing with QuantiFERON-TB gold Cytom Part B Clin Cytom 78 2010 71 80 10.1002/cyto.b.20503
118. C.S. Lindestam Arlehamn, D. Lewinsohn, A. Sette, and D. Lewinsohn Antigens for CD4 and CD8 T cells in tuberculosis Cold Spring Harb Perspect Med 4 2014 10.1101/cshperspect.a018465 a018465
119. C.S. Lindestam Arlehamn, and A. Sette Definition of CD4 immunosignatures associated with MTB Front Immunol 5 2014 124 10.3389/fimmu.2014.00124
120. S. Cho, V. Mehra, S. Thoma-Uszynski, S. Stenger, N. Serbina, R.J. Mazzaccaro, J.L. Flynn, P.F. Barnes, S. Southwood, E. Celis, B.R. Bloom, R.L. Modlin, and A. Sette Antimicrobial activity of MHC class I-restricted CD8+ T cells in human tuberculosis Proc Natl Acad Sci U S A 97 2000 12210 12215
121. M.P. Girard, U. Fruth, and M.P. Kieny A review of vaccine research and development: tuberculosis Vaccine 23 2005 5725 5731 10.1016/j.vaccine.2005.07.045
122. S. Reed, and Y. Lobet Tuberculosis vaccine development; from mouse to man Microb Infect 7 2005 922 931 10.1016/j.micinf.2005.03.011
123. G. Mamo, A. Mihret, M. Taffesse, G. Gebru, M. Afework, L.K. Yamuah, L. Wassie, M. Abebe, A. Aseffa, and S.K. Parida T cell response to alpha crystalline and Mycobacterium tuberculosis specific antigens using ex-vivo elispot assay for detecting latent tuberculosis infection in Addis Ababa, Ethiopia Ethiop Med J Suppl. 1 2014 15 22
124. M.R. Nyendak, B. Park, M.D. Null, J. Baseke, G. Swarbrick, H. Mayanja-Kizza, M. Nsereko, D.F. Johnson, P. Gitta, A. Okwera, S. Goldberg, L. Bozeman, J.L. Johnson, W.H. Boom, D.A. Lewinsohn, D.M. Lewinsohn Tuberculosis Research U the Tuberculosis Trials C Mycobacterium tuberculosis specific CD8(+) T cells rapidly decline with antituberculosis treatment PLoS One 8 2013 e81564 10.1371/journal.pone.0081564
125. J.S. Sutherland, M.K. Lalor, G.F. Black, L.R. Ambrose, A.G. Loxton, N.N. Chegou, D. Kassa, A. Mihret, R. Howe, H. Mayanja-Kizza, M.P. Gomez, S. Donkor, K. Franken, W. Hanekom, M.R. Klein, S.K. Parida, W.H. Boom, B.A. Thiel, A.C. Crampin, M. Ota, G. Walzl, T.H. Ottenhoff, H.M. Dockrell, S.H. Kaufmann Consortium GBfT Analysis of host responses to Mycobacterium tuberculosis antigens in a multi-site study of subjects with different TB and HIV infection states in sub-Saharan Africa PLoS One 8 2013 e74080 10.1371/journal.pone.0074080
126. Y. Yamashita, Y. Hoshino, M. Oka, S. Matsumoto, H. Ariga, H. Nagai, M. Makino, K. Ariyoshi, and Y. Tsunetsugu-Yokota Multicolor flow cytometric analyses of CD4+ T cell responses to Mycobacterium tuberculosis-related latent antigens Jpn J Infect Dis 66 2013 207 215
127. K. Yuan, X. Wu, Q. Zhang, Z. Zhong, and J. Chen Enzyme-linked immunospot assay response to recombinant CFP-10/ESAT-6 fusion protein among patients with spinal tuberculosis: implications for diagnosis and monitoring of surgical therapy Int J Infect Dis IJID Off Publ Int Soc Infect Dis 17 2013 e733 738 10.1016/j.ijid.2013.02.027
128. E. Borgstrom, P. Andersen, F. Atterfelt, I. Julander, G. Kallenius, M. Maeurer, I. Rosenkrands, M. Widfeldt, J. Bruchfeld, and H. Gaines Immune responses to ESAT-6 and CFP-10 by FASCIA and multiplex technology for diagnosis of M. Tuberculosis infection; IP-10 is a promising marker PloS One 7 2012 10.1371/journal.pone.0043438 e43438
129. R. van Altena, S. Duggirala, M.I. Groschel, and T.S. van der Werf Immunology in tuberculosis: challenges in monitoring of disease activity and identifying correlates of protection Curr Pharm Des 17 2011 2853 2862
130. D.S. Van-Lume, J.R. De Souza, M.M. Cabral, J.C. Rego, V. Balbino, M.H. Saad, H.C. Schindler, F.G. Abath, and S.M. Montenegro Immunological diagnosis of tuberculosis based on recombinant antigens ESAT-6 and CFP-10 in children from an endemic area in northeast Brazil Scand J Immunol 72 2010 460 468 10.1111/j.1365-3083.2010.02459.x
131. I. Leroux-Roels, S. Forgus, F. De Boever, F. Clement, M.A. Demoitie, P. Mettens, P. Moris, E. Ledent, G. Leroux-Roels, O. Ofori-Anyinam, and M.S. Group Improved CD4(+) T cell responses to Mycobacterium tuberculosis in PPD-negative adults by M72/AS01 as compared to the M72/AS02 and Mtb72F/AS02 tuberculosis candidate vaccine formulations: a randomized trial Vaccine 31 2013 2196 2206 10.1016/j.vaccine.2012.05.035
132. J. Dietrich, C. Aagaard, R. Leah, A.W. Olsen, A. Stryhn, T.M. Doherty, and P. Andersen Exchanging ESAT6 with TB10.4 in an Ag85B fusion molecule-based tuberculosis subunit vaccine: efficient protection and ESAT6-based sensitive monitoring of vaccine efficacy J Immunol 174 2005 6332 6339
133. S. Bertholet, G.C. Ireton, D.J. Ordway, H.P. Windish, S.O. Pine, M. Kahn, T. Phan, I.M. Orme, T.S. Vedvick, S.L. Baldwin, R.N. Coler, and S.G. Reed A defined tuberculosis vaccine candidate boosts BCG and protects against multidrug-resistant Mycobacterium tuberculosis Sci Transl Med 2 2010 10.1126/scitranslmed.3001094 53ra74
134. R.N. Coler, S. Bertholet, S.O. Pine, M.T. Orr, V. Reese, H.P. Windish, C. Davis, M. Kahn, S.L. Baldwin, and S.G. Reed Therapeutic immunization against Mycobacterium tuberculosis is an effective adjunct to antibiotic treatment J Infect Dis 207 2013 1242 1252 10.1093/infdis/jis425
135. B. Abel, M. Tameris, N. Mansoor, S. Gelderbloem, J. Hughes, D. Abrahams, L. Makhethe, M. Erasmus, M. de Kock, L. van der Merwe, A. Hawkridge, A. Veldsman, M. Hatherill, G. Schirru, M.G. Pau, J. Hendriks, G.J. Weverling, J. Goudsmit, D. Sizemore, J.B. McClain, M. Goetz, J. Gearhart, H. Mahomed, G.D. Hussey, J.C. Sadoff, and W.A. Hanekom The novel tuberculosis vaccine, AERAS-402, induces robust and polyfunctional CD4+ and CD8+ T cells in adults Am J Respir Crit Care Med 181 2010 1407 1417 10.1164/rccm.200910-1484OC
136. M. Havenga, R. Vogels, D. Zuijdgeest, K. Radosevic, S. Mueller, M. Sieuwerts, F. Weichold, I. Damen, J. Kaspers, A. Lemckert, M. van Meerendonk, R. van der Vlugt, L. Holterman, D. Hone, Y. Skeiky, R. Mintardjo, G. Gillissen, D. Barouch, J. Sadoff, and J. Goudsmit Novel replication-incompetent adenoviral B-group vectors: high vector stability and yield in PER.C6 cells J Gen Virol 87 2006 2135 2143 10.1099/vir.0.81956-0
137. E.M. Agger, I. Rosenkrands, A.W. Olsen, G. Hatch, A. Williams, C. Kritsch, K. Lingnau, A. von Gabain, C.S. Andersen, K.S. Korsholm, and P. Andersen Protective immunity to tuberculosis with Ag85B-ESAT-6 in a synthetic cationic adjuvant system IC31 Vaccine 24 2006 5452 5460 10.1016/j.vaccine.2006.03.072
138. J. Dietrich, C. Andersen, R. Rappuoli, T.M. Doherty, C.G. Jensen, and P. Andersen Mucosal administration of Ag85B-ESAT-6 protects against infection with Mycobacterium tuberculosis and boosts prior bacillus Calmette-Guerin immunity J Immunol 177 2006 6353 6360
139. A. Weinrich Olsen, L.A. van Pinxteren, L. Meng Okkels, P. Birk Rasmussen, and P. Andersen Protection of mice with a tuberculosis subunit vaccine based on a fusion protein of antigen 85b and esat-6 Infect Immun 69 2001 2773 2778 10.1128/iai.69.5.2773-2778.2001
140. D. Kaushal, T.W. Foreman, U.S. Gautam, T. Adekambi, J. Rangel-Moreno, N.A. Golden, A.F. Johnson-May, C.J. Roy, P.J. Didier, L.A. Doyle, K.E. Russell-Lodrigue, J.L. Blanchard, J. Rengarajan, A.A. Lackner, S.A. Khader, and S. Mehra Mucosal vaccination with attenuated Mycobacterium tuberculosis induces strong central memory responses and protects against tuberculosis Nat Commun 6 2015 8533 10.1038/ncomms9533